Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Assmann
U Schmidt
M Drechsler
M Pfannkuche

Showing results (1-10 of 1,190) with videos related to

Pageof 119
Sort By:
European Heart Journal|December 1, 1990
Genes and dyslipoproteinaemiasG Assmann
Infusionstherapie Und Klinische Ernahrung|August 1, 1983
[The physiology of lipoprotein metabolism]G Assmann
The Canadian Journal of Cardiology|July 1, 1988
European Consensus on Primary Prevention of Coronary Heart DiseaseG Assmann
The American Journal of Cardiology|March 21, 2001
Pro and con: high-density lipoprotein, triglycerides, and other lipid subfractions are the future of lipid managementG Assmann
Klinische Wochenschrift|January 15, 1979
[Tangier-disease (author's transl)]G Assmann
Biomedizinische Technik. Biomedical Engineering|August 25, 2005
[Assessment of cardiovascular risk--PROCAM and new algorithms]G Assmann
The American Journal of Cardiology|March 20, 1990
At what levels of total low- or high-density lipoprotein cholesterol should diet/drug therapy be initiated? European guidelinesG Assmann
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|November 14, 2007
[How often are dates of prescription and dispensing of drugs correct in claims data?]F Hoffmann, M Pfannkuche, G Glaeske
Der Nervenarzt|April 26, 2007
[High usage of zolpidem and zopiclone. Cross-sectional study using claims data]F Hoffmann, M Pfannkuche, G Glaeske
Drugs|January 1, 1990
Primary prevention of coronary heart disease in the Federal Republic of Germany. Analysis of cost-effectivenessG Assmann, H Schulte
Pageof 119

Showing results (1-10 of 1,190) with videos related to

Sort By:
Pageof 119
European Heart Journal|December 1, 1990
Genes and dyslipoproteinaemiasG Assmann
Infusionstherapie Und Klinische Ernahrung|August 1, 1983
[The physiology of lipoprotein metabolism]G Assmann
The Canadian Journal of Cardiology|July 1, 1988
European Consensus on Primary Prevention of Coronary Heart DiseaseG Assmann
The American Journal of Cardiology|March 21, 2001
Pro and con: high-density lipoprotein, triglycerides, and other lipid subfractions are the future of lipid managementG Assmann
Klinische Wochenschrift|January 15, 1979
[Tangier-disease (author's transl)]G Assmann
Biomedizinische Technik. Biomedical Engineering|August 25, 2005
[Assessment of cardiovascular risk--PROCAM and new algorithms]G Assmann
The American Journal of Cardiology|March 20, 1990
At what levels of total low- or high-density lipoprotein cholesterol should diet/drug therapy be initiated? European guidelinesG Assmann
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|November 14, 2007
[How often are dates of prescription and dispensing of drugs correct in claims data?]F Hoffmann, M Pfannkuche, G Glaeske
Der Nervenarzt|April 26, 2007
[High usage of zolpidem and zopiclone. Cross-sectional study using claims data]F Hoffmann, M Pfannkuche, G Glaeske
Drugs|January 1, 1990
Primary prevention of coronary heart disease in the Federal Republic of Germany. Analysis of cost-effectivenessG Assmann, H Schulte
Pageof 119